logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Osteoarthritis Of Hip

    Medications for Osteoarthritis Of Hip

    FiltersReset Filters
    23 results

    • celebrex

      (Celecoxib)
      Viatris Specialty LLC
      Usage: CELEBREX is indicated for the management of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis in patients 2 years and older, ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

    • celecoxib

      (CELECOXIB)
      NIVAGEN PHARMACEUTICALS, INC.
      Usage: Celecoxib capsules are indicated for managing signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

    • celecoxib

      (Celecoxib)
      Chartwell RX, LLC
      Usage: Celecoxib is indicated for the management of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (for patients aged 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

    • celecoxib

      (Celecoxib)
      Yiling Pharmaceutical, Inc.
      Usage: Celecoxib capsules are indicated for managing signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Hikma Pharmaceuticals USA Inc.
      Usage: This drug is indicated for intravenous or intramuscular use in various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., rheumatoid arthritis), allergic states, skin diseases, and gastrointestinal issues. It also addresses respiratory, hematologic, neoplastic, and nervous system disorders, with specific applications for intra-articular, soft tissue, and intralesional administration.

    • diclofenac potassium

      (diclofenac potassium)
      SOLA Pharmaceuticals, LLC
      Usage: Diclofenac potassium tablets are indicated for the treatment of primary dysmenorrhea, relief of mild to moderate pain, and alleviation of signs and symptoms associated with osteoarthritis and rheumatoid arthritis. Use the lowest effective dose for the shortest duration to minimize risks.

    • diclofenac potassium

      (diclofenac potassium)
      Advagen Pharma Ltd
      Usage: Diclofenac potassium tablets are indicated for the treatment of primary dysmenorrhea, relief of mild to moderate pain, and alleviation of signs and symptoms associated with osteoarthritis and rheumatoid arthritis. Use the lowest effective dose for the shortest duration to minimize risks.

    • diclofenac potassium

      (diclofenac potassium, film coated)
      INA Pharmaceutics Inc,
      Usage: Diclofenac potassium tablets are indicated for treating primary dysmenorrhea, relieving mild to moderate pain, and alleviating signs and symptoms of osteoarthritis and rheumatoid arthritis. Use the lowest effective dose for the shortest duration to minimize risks.

    • diclofenac potassium

      (Diclofenac Potassium Tablets)
      UMEDICA LABORATORIES PRIVATE LIMITED
      Usage: Diclofenac potassium immediate-release tablets are indicated for treating primary dysmenorrhea, relieving mild to moderate pain, and alleviating symptoms of osteoarthritis and rheumatoid arthritis. Use the lowest effective dose for the shortest duration, considering benefits and risks.

    • etodolac

      (Etodolac)
      ANI Pharmaceuticals, Inc.
      Usage: Etodolac capsules are indicated for the management of signs and symptoms of osteoarthritis, rheumatoid arthritis, and for the treatment of acute pain. Consideration of benefits, risks, and the lowest effective dose for the shortest duration is advised.